Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update of knowledge on PD‐L1 in head and neck cancers: Physiologic, prognostic and therapeutic perspectives
Daniel Lenouvel, Miguel Ángel González‐Moles, Asmae Talbaoui, et al.
Oral Diseases (2019) Vol. 26, Iss. 3, pp. 511-526
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
Elizabeth Paver, Wendy A. Cooper, Andrew J. Colebatch, et al.
Pathology (2020) Vol. 53, Iss. 2, pp. 141-156
Closed Access | Times Cited: 198
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis
Daniel Lenouvel, Miguel Ángel González‐Moles, Isabel Ruiz‐Ávila, et al.
Oral Oncology (2020) Vol. 106, pp. 104722-104722
Closed Access | Times Cited: 64
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy
Gaetano Paolino, Liron Pantanowitz, Valeria Barresi, et al.
Pathology - Research and Practice (2021) Vol. 226, pp. 153605-153605
Closed Access | Times Cited: 53
PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside
Riccardo Nocini, Matteo Vianini, Ilaria Girolami, et al.
Clinical and Experimental Dental Research (2022) Vol. 8, Iss. 3, pp. 690-698
Open Access | Times Cited: 33
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
Xiao-kun Zhang, Ye Wu, Jia-Yi Lin, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3818-3833
Open Access | Times Cited: 8
Immunomodulatory aspects in the progression and treatment of oral malignancy
Nobuo Kondoh, Masako Mizuno‐Kamiya, Naoki Umemura, et al.
Japanese Dental Science Review (2019) Vol. 55, Iss. 1, pp. 113-120
Open Access | Times Cited: 44
Understanding the complex pathogenesis of oral cancer: A comprehensive review
Maria Georgaki, Vasileios Ionas Theofilou, Efstathios Pettas, et al.
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology (2021) Vol. 132, Iss. 5, pp. 566-579
Closed Access | Times Cited: 33
MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1
Jingran Sun, Xiao Zhang, Ya Zhang
Cellular & Molecular Biology Letters (2019) Vol. 24, Iss. 1
Open Access | Times Cited: 39
Clinicopathological and prognostic significance of PD‐L1 in oral cancer: A preliminary retrospective immunohistochemistry study
Daniel Lenouvel, Miguel Ángel González‐Moles, Isabel Ruiz‐Ávila, et al.
Oral Diseases (2020) Vol. 27, Iss. 2, pp. 173-182
Closed Access | Times Cited: 37
The clinicopathological significance of PD-L1 expression assessed by the combined positive score (CPS) in head and neck squamous cell carcinoma
Dilinaer Wusiman, Lei Guo, Zehao Huang, et al.
Pathology - Research and Practice (2022) Vol. 236, pp. 153934-153934
Open Access | Times Cited: 20
Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews
Miguel Ángel González‐Moles, Saman Warnakulasuriya, María López-Ansio, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3834-3834
Open Access | Times Cited: 20
Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy
Suqin Zhang, Meng Li, Jingyi Zeng, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Miguel Ángel González‐Moles, Ángela Ayén, Isabel González‐Ruiz, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2393-2393
Open Access | Times Cited: 29
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
Silvia Pisani, Giulia Bertino, Adriele Prina‐Mello, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 17
Predictive factors in the treatment of oral squamous cell carcinoma using PD-1/PD-L1 inhibitors
Antian Gao, Pan Xiao, Xudong Yang, et al.
Investigational New Drugs (2021) Vol. 39, Iss. 4, pp. 1132-1138
Closed Access | Times Cited: 22
Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology
Hans Prakash Sathasivam, Ralf Kist, Philip Sloan, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 3, pp. 413-421
Open Access | Times Cited: 22
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis
Lijie Li, Peter Mu‐Hsin Chang, Chien‐Hsiu Li, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses
Miguel Ángel González‐Moles, Carmen Keim-del Pino, Pablo Ramos‐García
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13099-13099
Open Access | Times Cited: 16
Is Systemic Immunosuppression a Risk Factor for Oral Cancer? A Systematic Review and Meta-Analysis
Romeo Patini, Massimo Cordaro, Denise Marchesini, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3077-3077
Open Access | Times Cited: 8
Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward
Alessandro Antonelli, Anna Martina Battaglia, Alessandro Sacco, et al.
Frontiers in Oral Health (2024) Vol. 5
Open Access | Times Cited: 3
Spatial Intratumoral Heterogeneity Expression of PD-L1 Antigen in Head and Neck Squamous Cell Carcinoma
Nir Hirshoren, Issa Al-kharouf, Jeffrey M. Weinberger, et al.
Oncology (2021) Vol. 99, Iss. 7, pp. 464-470
Open Access | Times Cited: 19
PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
Katarzyna Malinowska, Andrzej Kowalski, Anna Merecz-Sadowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2033-2033
Open Access | Times Cited: 7
PD‐L1 expression patterns in oral cancer as an integrated approach for further prognostic classification
Marisol Miranda Galvis, Alícia Rumayor Piña, Raísa Sales de Sá, et al.
Oral Diseases (2020) Vol. 27, Iss. 7, pp. 1699-1710
Closed Access | Times Cited: 19
Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature
Francisco Esteban, Pablo Ramos‐García, Miguel Muñoz, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 375-375
Open Access | Times Cited: 17
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
Cláudia Viegas, Daniela S. M. Pereira, Pedro Fonte
Materials (2022) Vol. 15, Iss. 6, pp. 2086-2086
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top